Results 111 to 120 of about 731,396 (195)
When blood is needed but not available: A proposal for measuring patient‐level blood unavailability
Transfusion, EarlyView.
Shreenik Kundu +3 more
wiley +1 more source
ABSTRACT Chemical compliance remains the usual endpoint for closing contaminated‐soil remediation projects, although it does not establish recovery of soil function or the durability of the post‐treatment state. This critical review examines when microbiological evidence can contribute to ecological closure decisions.
Mariusz Cycoń
wiley +1 more source
Fc mutagenesis enhances the functionality of anti-RhD monoclonal antibodies
Hemolytic disease of the fetus and newborn (HDFN) due to Rhesus D (RhD) antigen mismatch between the mother and fetus has been a significant cause of neonatal jaundice, recurrent miscarriage, and stillbirth throughout history.
Wicks, IP +4 more
core +1 more source
MOLECULAR BASIS DETERMINATION OF D VARIANTS: NARRATIVE REVIEW
Objective: The Rh blood group is one of the most complex blood groups known in humans, being is clinically relevant mainly due to the fact that antigens are highly immunogenic, responsible for a hemolytic transfusion reaction or on fetal RBCs.
ACS Castro +9 more
doaj +1 more source
TPET‐F2CN CMP exhibited higher CO2 uptake (2.88 mmol g−1 at 273 K) and superior Rhd B adsorption, with an equilibrium capacity of 98.12 mg g−1 and a maximum monolayer capacity of 155.6 mg g−1. ABSTRACT Herein, two conjugated microporous polymers (CMPs), TPET‐FO and TPET‐F2CN, are functionalized with carbonyl and nitrile groups.
Mohamed Gamal Mohamed +8 more
wiley +1 more source
Abstract Introduction To develop and validate a single‐nucleotide polymorphism (SNP)‐based noninvasive prenatal cell‐free DNA (cfDNA) screening algorithm capable of identifying the cfDNA signal of the living fetus in vanishing twin (VT) pregnancies and assessing that twin's aneuploidy risk. Methods Prospective study enrolling participants ≥18 years old
Lorraine Dugoff +29 more
wiley +1 more source
Antigen D drugi je najimunogeničniji antigen sustava krvnih grupa. Varijanta RHD označava promjenu u ekspresiji proteina RhD. Transfuzijsko liječenje varijanti RHD ovisi o riziku pojedine varijante da razvije anti-D aloprotutijela.
Kopilović, Patricija
core
Nanometer‐sized Rh clusters provide a specific reaction environment that facilitates the balanced co‐adsorption of styrene, CO, and H, thereby promoting hydroformylation. ABSTRACT The size of the reactive metal domain, termed an ‘ensemble’, in supported metal catalysts critically influences their catalytic activity.
Yuki Nakaya +5 more
wiley +1 more source
Diversity of RHD virus: epidemiological, diagnostic and immunological importance
Rabbit haemorrhagic disease (RHD) was first recognized in China in 1984. In Europe, the disease appeared in 1986 in Italy, and in the following years RHD was observed in many other European countries, including Poland in 1988.
Wiesław Niedbalski, Andrzej Fitzner
core +1 more source
In this series of 19 DCD donors using TA‐NRP, 89.5% of hearts were successfully transplanted with no PGD, no postoperative ECMO, and no 30‐day mortality, demonstrating the feasibility and safety of this approach. ABSTRACT Controlled donation after circulatory death (cDCD) with thoracoabdominal normothermic regional perfusion (TA‐NRP) has emerged ...
Maria Benedetto +11 more
wiley +1 more source

